Disseminated primary coccidioidomycosis of the chest wall  by Evans, Kimberly et al.
Brief Clinical ReportsDisseminated primary coccidioidomycosis of the chest wallKimberly Evans, MD,a Royce F. Calhoun, MD,a Hugh Black, MD,b and David T. Cooke, MD,a
Sacramento, CalifFIGURE1. High-poweredmicrograph ofCoccidioides species spherule in
skeletal muscle tissue (circle).Pulmonary coccidioidomycosis, or valley fever, is a diagno-
sis with increasing incidence in the western United States.
Although coccidioidomycosis is an infectious disease clas-
sically described to be endemic to the southwestern United
States, the first cases were indentified in central California.1
One defined population that has been especially subject to
this disease is residents of the greater Sacramento counties
in California, with 0.1 to 5.0 cases per 100,000 population
from 2001 to 2008.2 Coccidioidomycosis spreads through
inhalation of aerosolized mold or arthroconidia. Although
pulmonary (acute pneumonia, chronic progressive pneumo-
nia, and pulmonary nodules) and certain extrapulmonary
(nonmeningeal and meningitis) manifestations of coccidioi-
domycosis infection are well described, treatment of dis-
seminated coccidioidomycosis presenting as chest wall
disease is not.
In this report we present 2 cases that illustrate the clinical
presentation and treatment strategy of disseminated coccid-
ioidomycosis infection of the chest wall.CLINICAL SUMMARY
Patient 1
A 36-year-old African American man presented with the
complaints of anterior precordial and left shoulder discom-
fort. On examination, he had a large tender mass of his prox-
imal sternum and drainage from his left shoulder. Computed
tomographic scanning of the chest and abdomen demon-
strated an 8 3 3.5 3 5–cm fluid collection of his sternum
and anterior chest wall and small fluid collections of his
left acromion and right iliac fossa. He underwent partial ster-
nectomy, resection of the bilateral medial pectoralis major
muscles, placement of a wound vacuum dressing (KCI,
San Antonio, Tex), and simple drainage of the left acromial
and right iliac fossa lesions.
Wound culture confirmed Coccidioides immitis. Surgical
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was started on AmBisome (liposomal amphotericin B; Gi-
lead, Foster City, Calif). After resolution of his systemic
symptoms, he returned to the operating room for pectoralis
major muscle advancement flaps and primary closure of his
anterior chest wall. The patient was discharged approxi-
mately 1 month after his initial hospitalization on indefinite
oral fluconazole. He continues to have a well-healed wound
without recurrent disease more than 12 months after pre-
sentation.Patient 2
A 43-year-old Latino man presented to another medical
facility with a presternal skin lesion that was debrided.
Wound cultures revealed C immitis. He was initially
treated with diflucan, with no resolution of his lesion.
The patient underwent additional simple local debride-
ments, and his antifungal regimen was changed to posaco-
nazole (Merck, Whitehouse Station, NJ). He had low-grade
fevers and chills and a 40-pound weight loss. He was sub-
sequently transferred to our medical center. A computed
tomographic scan demonstrated a large anterior chest
wall mass replacing the manubrium of the sternum, with
invasion into the pectoralis muscle and the anterior medias-
tinum (Figure 2), and there was a peripheral 2.1-cm middle
lobe nodule.
The patient underwent a radical sternectomy with soft
tissue debridement of his bilateral pectoralis muscles. Theery c November 2010
FIGURE 2. Contrast-enhanced axial computed tomographic scan shows
bony destruction of the sternum and invasion into adjacent chest wall soft
tissue and the anterior mediastinum by fungus (oval).
Brief Clinical Reportsfungal infection encapsulated his innominate vein, requir-
ing ligation. He also underwent right middle lobe wedge
resection for the small focus of pulmonary coccidioidomy-
cosis. Eight days after the original procedure, the patient
underwent bilateral pectoral advancement flaps, omental
flap, and a split-thickness skin graft. He had no further
symptoms, his wounds are well healed, and he remains
in good condition more than 24 months after presentation
and is on lifetime voriconazole (Pfizer, New York, NY)
therapy.
DISCUSSION
The first report of coccidioidomycosis was in 1892.3 Al-
though any organ system can be involved in disseminated
disease, most publications elucidate the pulmonary orThe Journal of Thoracic and Cacentral nervous system sequelae of coccidioidomycosis in-
fection. Risk factors for extrapulmonary disease include ex-
tremes of age, African or Filipino ancestry (similar to our
patients), pregnancy, and immunosuppression.1
The most common treatment for coccidioidomycosis in-
fection is antifungal therapy with oral azoles, such as fluco-
nazole, and amphotericin B is considered during complex
infections.1 There are only rare reports on the management
of primary chest wall coccidioidomycosis infection. Crum
and colleagues4 described 2 patients who had involvement
of the sternum or sternoclavicular joint.
Our patients, both of whom were immunocompetent, pre-
sented with aggressive primary chest wall disease. Because
of the severe nature of the chest wall infection, we adopted
a therapeutic approach similar to those for other aggressive
fungal infections, such as zygomycosis, specifically radical
surgical resection of the infected chest wall in concurrence
with systemic antifungal agents.5 After resolution of symp-
toms, the chest wall is reconstructed, and the patients are
started on indefinite oral antifungals for what suggests
lasting successful results.
In conclusion, radical chest wall resection and reconstruc-
tion followed by long-term or lifetime antifungal therapy
appears to be the treatment of choice for extensive coccidi-
oidomycosis disease of the chest wall.References
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